These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33728716)

  • 1. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
    Okabe A; Kaneda A
    Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
    Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
    Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
    Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer deregulation in cancer and other diseases.
    Herz HM
    Bioessays; 2016 Oct; 38(10):1003-15. PubMed ID: 27570183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
    Jia Q; Chen S; Tan Y; Li Y; Tang F
    Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
    Cohen AJ; Saiakhova A; Corradin O; Luppino JM; Lovrenert K; Bartels CF; Morrow JJ; Mack SC; Dhillon G; Beard L; Myeroff L; Kalady MF; Willis J; Bradner JE; Keri RA; Berger NA; Pruett-Miller SM; Markowitz SD; Scacheri PC
    Nat Commun; 2017 Feb; 8():14400. PubMed ID: 28169291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
    Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
    Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited Review: The role and contribution of transcriptional enhancers in brain cancer.
    Arabzade A; Stuckert AJ; Bertrand KC; Mack SC
    Neuropathol Appl Neurobiol; 2020 Feb; 46(1):48-56. PubMed ID: 32109328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers.
    Mikulasova A; Kent D; Trevisan-Herraz M; Karataraki N; Fung KTM; Ashby C; Cieslak A; Yaccoby S; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Morgan GJ; Asnafi V; Spicuglia S; Brackley CA; Corcoran AE; Hambleton S; Walker BA; Rico D; Russell LJ
    Genome Res; 2022 Jul; 32(7):1343-1354. PubMed ID: 34933939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Enhancers in Leukemia.
    Mulet-Lazaro R; Delwel R
    Blood Cancer Discov; 2024 Sep; 5(5):303-317. PubMed ID: 39093124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of super-enhancer reprogramming and activation in cancer.
    Zhou RW; Parsons RE
    Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs.
    Flavahan WA; Drier Y; Johnstone SE; Hemming ML; Tarjan DR; Hegazi E; Shareef SJ; Javed NM; Raut CP; Eschle BK; Gokhale PC; Hornick JL; Sicinska ET; Demetri GD; Bernstein BE
    Nature; 2019 Nov; 575(7781):229-233. PubMed ID: 31666694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p63 Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape.
    Qu J; Tanis SEJ; Smits JPH; Kouwenhoven EN; Oti M; van den Bogaard EH; Logie C; Stunnenberg HG; van Bokhoven H; Mulder KW; Zhou H
    Cell Rep; 2018 Dec; 25(12):3490-3503.e4. PubMed ID: 30566872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection.
    Vierbuchen T; Ling E; Cowley CJ; Couch CH; Wang X; Harmin DA; Roberts CWM; Greenberg ME
    Mol Cell; 2017 Dec; 68(6):1067-1082.e12. PubMed ID: 29272704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core regulatory circuitries in defining cancer cell identity across the malignant spectrum.
    Jahangiri L; Tsaprouni L; Trigg RM; Williams JA; Gkoutos GV; Turner SD; Pereira J
    Open Biol; 2020 Jul; 10(7):200121. PubMed ID: 32634370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression.
    Zhang J; Wang Q; Qi S; Duan Y; Liu Z; Liu J; Zhang Z; Li C
    J Transl Med; 2024 Jun; 22(1):547. PubMed ID: 38849954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.